世界のインスリンAPI産業2020-2026

• 英文タイトル:Global Insulin API Industry Research Report, Growth Trends and Competitive Analysis 2020-2026

Global Insulin API Industry Research Report, Growth Trends and Competitive Analysis 2020-2026「世界のインスリンAPI産業2020-2026」(市場規模、市場予測)調査レポートです。• レポートコード:D0MA3012024
• 出版社/出版日:QYResearch / 2020年1月
• レポート形態:英文、PDF、112ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:製薬・医療
• 販売価格(消費税別)
  Single User¥534,100 (USD4,900)▷ お問い合わせ
  Multi User¥801,150 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,068,200 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当リサーチレポートでは、インスリンAPIの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、インスリンAPIのグローバル市場動向、メーカー別競争状況、種類別市場規模(通常用ヒトインスリン、インスリンアナログ)、用途別市場規模(速効型、プレミックス、長時間作動型)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。
・レポート概要
・グローバル市場動向
・メーカー別競争状況
・インスリンAPIの種類別市場2015-2026:通常用ヒトインスリン、インスリンアナログ
・インスリンAPIの用途別市場2015-2026:速効型、プレミックス、長時間作動型
・インスリンAPIの北米市場分析
・インスリンAPIのアジア市場分析
・インスリンAPIの中南米市場分析
・インスリンAPIの中東・アフリカ市場分析
・関連企業情報:Novo Nordisk、Sanofi-Aventis、Eli Lilly、Tonghua Dongbao、United Laboratory、Biocon、Torrent Pharma、Amphastar、Ganlee、Julphar Diabetes、Wockhardt
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論

Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.
Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
In 2019, the global Insulin API market size was US$ 1812.1 million and is forecast to US$ 2441.2 million in 2026, growing at a CAGR of 4.3% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Insulin API.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Insulin API market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Insulin API market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Insulin API market. Readers of the report can become informed about current and future trends of the global Insulin API market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Insulin API markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Insulin API market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Insulin API market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Insulin API market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Insulin API market is segmented into
Regular Human Insulin
Insulin Analogue

Market Segment by Application, the Insulin API market is segmented into
Fast-acting
Premix
Long-acting

This report includes the following manufacturers; we can also add the other companies as you want.
Novo Nordisk
Sanofi-Aventis
Eli Lilly
Tonghua Dongbao
United Laboratory
Biocon
Torrent Pharma
Amphastar
Ganlee
Julphar Diabetes
Wockhardt

The study objectives are:
To analyze and research the global Insulin API status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Insulin API manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Insulin API are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

レポート目次

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Insulin API Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Insulin API Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Regular Human Insulin
1.3.3 Insulin Analogue
1.4 Market Segment by Application
1.4.1 Global Insulin API Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Fast-acting
1.4.3 Premix
1.4.4 Long-acting
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Insulin API Revenue (2015-2026)
2.1.1 Global Insulin API Revenue (2015-2026)
2.1.2 Global Insulin API Sales (2015-2026)
2.2 Insulin API Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Insulin API Sales by Regions (2015-2020)
2.2.2 Global Insulin API Revenue by Regions (2015-2020)
2.3 Global Top Insulin API Regions (Countries) Ranking by Market Size
2.4 Insulin API Industry Trends
2.4.1 Insulin API Market Top Trends
2.4.2 Market Drivers
2.4.3 Insulin API Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Insulin API Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Insulin API Manufacturers by Sales (2015-2020)
3.1.1 Global Insulin API Sales by Manufacturers (2015-2020)
3.1.2 Global Insulin API Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Insulin API Sales in 2019
3.2 Global Top Manufacturers Insulin API by Revenue
3.2.1 Global Insulin API Revenue by Manufacturers (2015-2020)
3.2.2 Global Insulin API Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Insulin API Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2019)
3.4 Global Insulin API Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Insulin API Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Insulin API Market
3.7 Key Manufacturers Insulin API Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Insulin API Historic Market Review by Type (2015-2020)
4.1.2 Global Insulin API Sales Market Share by Type (2015-2020)
4.1.3 Global Insulin API Revenue Market Share by Type (2015-2020)
4.1.4 Insulin API Price by Type (2015-2020)
4.1 Global Insulin API Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Insulin API Sales Forecast by Type (2021-2026)
4.2.3 Global Insulin API Revenue Forecast by Type (2021-2026)
4.2.4 Insulin API Price Forecast by Type (2021-2026)

5 Global Insulin API Market Size by Application
5.1 Global Insulin API Historic Market Review by Application (2015-2020)
5.1.2 Global Insulin API Sales Market Share by Application (2015-2020)
5.1.3 Global Insulin API Revenue Market Share by Application (2015-2020)
5.1.4 Insulin API Price by Application (2015-2020)
5.2 Global Insulin API Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Insulin API Sales Forecast by Application (2021-2026)
5.2.3 Global Insulin API Revenue Forecast by Application (2021-2026)
5.2.4 Insulin API Price Forecast by Application (2021-2026)

6 North America
6.1 North America Insulin API Breakdown Data by Company
6.2 North America Insulin API Breakdown Data by Type
6.3 North America Insulin API Breakdown Data by Application
6.4 North America Insulin API Breakdown Data by Countries
6.4.1 North America Insulin API Sales by Countries
6.4.2 North America Insulin API Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Insulin API Breakdown Data by Company
7.2 Europe Insulin API Breakdown Data by Type
7.3 Europe Insulin API Breakdown Data by Application
7.4 Europe Insulin API Breakdown Data by Countries
7.4.1 Europe Insulin API Sales by Countries
7.4.2 Europe Insulin API Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Insulin API Breakdown Data by Company
8.2 Asia Pacific Insulin API Breakdown Data by Type
8.3 Asia Pacific Insulin API Breakdown Data by Application
8.4 Asia Pacific Insulin API Breakdown Data by Regions
8.4.1 Asia Pacific Insulin API Sales by Regions
8.4.2 Asia Pacific Insulin API Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Insulin API Breakdown Data by Company
9.2 Latin America Insulin API Breakdown Data by Type
9.3 Latin America Insulin API Breakdown Data by Application
9.4 Latin America Insulin API Breakdown Data by Countries
9.4.1 Latin America Insulin API Sales by Countries
9.4.2 Latin America Insulin API Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Insulin API Breakdown Data by Type
10.2 Middle East and Africa Insulin API Breakdown Data by Application
10.3 Middle East and Africa Insulin API Breakdown Data by Countries
10.3.1 Middle East and Africa Insulin API Sales by Countries
10.3.2 Middle East and Africa Insulin API Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Novo Nordisk Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Insulin API Products and Services
11.1.5 Novo Nordisk SWOT Analysis
11.1.6 Novo Nordisk Recent Developments
11.2 Sanofi-Aventis
11.2.1 Sanofi-Aventis Corporation Information
11.2.2 Sanofi-Aventis Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Sanofi-Aventis Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Sanofi-Aventis Insulin API Products and Services
11.2.5 Sanofi-Aventis SWOT Analysis
11.2.6 Sanofi-Aventis Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Corporation Information
11.3.2 Eli Lilly Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Eli Lilly Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Eli Lilly Insulin API Products and Services
11.3.5 Eli Lilly SWOT Analysis
11.3.6 Eli Lilly Recent Developments
11.4 Tonghua Dongbao
11.4.1 Tonghua Dongbao Corporation Information
11.4.2 Tonghua Dongbao Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Tonghua Dongbao Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Tonghua Dongbao Insulin API Products and Services
11.4.5 Tonghua Dongbao SWOT Analysis
11.4.6 Tonghua Dongbao Recent Developments
11.5 United Laboratory
11.5.1 United Laboratory Corporation Information
11.5.2 United Laboratory Business Overview and Total Revenue (2019 VS 2018)
11.5.3 United Laboratory Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 United Laboratory Insulin API Products and Services
11.5.5 United Laboratory SWOT Analysis
11.5.6 United Laboratory Recent Developments
11.6 Biocon
11.6.1 Biocon Corporation Information
11.6.2 Biocon Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Biocon Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Biocon Insulin API Products and Services
11.6.5 Biocon SWOT Analysis
11.6.6 Biocon Recent Developments
11.7 Torrent Pharma
11.7.1 Torrent Pharma Corporation Information
11.7.2 Torrent Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Torrent Pharma Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Torrent Pharma Insulin API Products and Services
11.7.5 Torrent Pharma SWOT Analysis
11.7.6 Torrent Pharma Recent Developments
11.8 Amphastar
11.8.1 Amphastar Corporation Information
11.8.2 Amphastar Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Amphastar Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Amphastar Insulin API Products and Services
11.8.5 Amphastar SWOT Analysis
11.8.6 Amphastar Recent Developments
11.9 Ganlee
11.9.1 Ganlee Corporation Information
11.9.2 Ganlee Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Ganlee Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Ganlee Insulin API Products and Services
11.9.5 Ganlee SWOT Analysis
11.9.6 Ganlee Recent Developments
11.10 Julphar Diabetes
11.10.1 Julphar Diabetes Corporation Information
11.10.2 Julphar Diabetes Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Julphar Diabetes Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Julphar Diabetes Insulin API Products and Services
11.10.5 Julphar Diabetes SWOT Analysis
11.10.6 Julphar Diabetes Recent Developments
11.11 Wockhardt
11.11.1 Wockhardt Corporation Information
11.11.2 Wockhardt Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Wockhardt Insulin API Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Wockhardt Insulin API Products and Services
11.11.5 Wockhardt SWOT Analysis
11.11.6 Wockhardt Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Insulin API Sales Channels
12.2.2 Insulin API Distributors
12.3 Insulin API Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Insulin API Sales Forecast (2021-2026)
13.1.1 Global Insulin API Sales Forecast by Regions (2021-2026)
13.1.2 Global Insulin API Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Insulin API Sales Forecast (2021-2026)
13.2.2 North America Insulin API Revenue Forecast (2021-2026)
13.2.3 North America Insulin API Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Insulin API Sales Forecast (2021-2026)
13.3.2 Europe Insulin API Revenue Forecast (2021-2026)
13.3.3 Europe Insulin API Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Insulin API Sales Forecast (2021-2026)
13.4.2 Asia Pacific Insulin API Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Insulin API Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Insulin API Sales Forecast (2021-2026)
13.5.2 Latin America Insulin API Revenue Forecast (2021-2026)
13.5.3 Latin America Insulin API Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Insulin API Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Insulin API Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Insulin API Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Insulin API Key Market Segments
Table 2. Ranking of Global Top Insulin API Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin API Market Size Growth Rate by Type 2021-2026 (Kg) & (Million US$)
Table 4. Major Manufacturers of Regular Human Insulin
Table 5. Major Manufacturers of Insulin Analogue
Table 6. Global Insulin API Market Share by Application 2019-2025 (Kg)
Table 7. Global Insulin API Market Size by Regions 2015-2020 (Kg) & (Million US$)
Table 8. Global Insulin API Sales by Regions 2015-2020 (Kg)
Table 9. Global Insulin API Sales Market Share by Regions 2015-2020
Table 10. Global Insulin API Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Insulin API Revenue Market Share by Regions 2015-2020
Table 12. Top Insulin API Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Insulin API Key Drivers: Impact Analysis (2021-2026)
Table 15. Insulin API Key Challenges
Table 16. Main Points Interviewed from Key Insulin API Players: Views for Future
Table 17. Global Insulin API Sales by Manufacturers (2015-2020) (Kg)
Table 18. Global Insulin API Sales Share by Manufacturers (2015-2020)
Table 19. Insulin API Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Insulin API Revenue Share by Manufacturers (2015-2020)
Table 21. Global Insulin API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin API as of 2019)
Table 23. Key Manufacturers Insulin API Average Selling Price (ASP) (2015-2020) (K USD/Kg)
Table 24. Key Manufacturers Insulin API Plants/Factories Distribution
Table 25. Key Manufacturers Insulin API Area Served
Table 26. Date of Key Manufacturers Enter into Insulin API Market
Table 27. Key Manufacturers Insulin API Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Regular Human Insulin Sales and Revenue (2015-2020) (Kg) & (Million US$)
Table 30. Global Insulin Analogue Sales and Revenue (2015-2020) (Kg) & (Million US$)
Table 31. Global Insulin API Sales (Kg) by Type (2015-2020)
Table 32. Global Insulin API Sales Share by Type (2015-2020)
Table 33. Global Insulin API Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Insulin API Price (Kg) by Type (2015-2020)
Table 35. Global Insulin API Sales (Kg) by Type (2021-2026)
Table 36. Global Insulin API Sales Share by Type (2021-2026)
Table 37. Global Insulin API Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Insulin API Revenue Share by Type (2021-2026)
Table 39. Global Insulin API Price (Kg) by Type (2021-2026)
Table 40. Global Insulin API Sales (Kg) by Application (2015-2020)
Table 41. Global Insulin API Sales Share by Application (2015-2020)
Table 42. Global Insulin API Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Insulin API Price by Application 2015-2020 (K USD/Kg)
Table 44. Global Insulin API Sales by Application (2015-2020) (Kg)
Table 45. Global Insulin API Sales Share by Application (2015-2020)
Table 46. Global Insulin API Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Insulin API Revenue Share by Application (2021-2026)
Table 48. Global Insulin API Price (Kg) by Application (2021-2026)
Table 49. North America Insulin API Sales by Company (2015-2020) (Kg)
Table 50. North America Insulin API Sales Market Share by Company (2015-2020)
Table 51. North America Insulin API Sales by Type (2015-2020) (Kg)
Table 52. North America Insulin API Sales Market Share by Type (2015-2020)
Table 53. North America Insulin API Sales by Application (2015-2020) (Kg)
Table 54. North America Insulin API Sales Market Share by Application (2015-2020)
Table 55. North America Insulin API Sales by Countries (2015-2020) (Kg)
Table 56. North America Insulin API Sales Market Share by Countries (2015-2020)
Table 57. North America Insulin API Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Insulin API Revenue Market Share by Countries (2015-2020)
Table 59. Europe Insulin API Sales by Company (2015-2020) (Kg)
Table 60. Europe Insulin API Sales Market Share by Company (2015-2020)
Table 61. Europe Insulin API Sales by Type (2015-2020) (Kg)
Table 62. Europe Insulin API Sales Market Share by Type (2015-2020)
Table 63. Europe Insulin API Sales by Application (2015-2020) (Kg)
Table 64. Europe Insulin API Sales Market Share by Application (2015-2020)
Table 65. Europe Insulin API Sales by Countries (2015-2020) (Kg)
Table 66. Europe Insulin API Sales Market Share by Countries (2015-2020)
Table 67. Europe Insulin API Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Insulin API Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Insulin API Sales by Regions (2015-2020) (Kg)
Table 70. Asia Pacific Insulin API Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Insulin API Sales by Type (2015-2020) (Kg)
Table 72. Asia Pacific Insulin API Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Insulin API Sales by Application (2015-2020) (Kg)
Table 74. Asia Pacific Insulin API Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Insulin API Sales by Countries (2015-2020) (Kg)
Table 76. Asia Pacific Insulin API Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Insulin API Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Insulin API Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Insulin API Sales by Company (2015-2020) (Kg)
Table 80. Latin America Insulin API Sales Market Share by Company (2015-2020)
Table 81. Latin America Insulin API Sales by Type (2015-2020) (Kg)
Table 82. Latin America Insulin API Sales Market Share by Type (2015-2020)
Table 83. Latin America Insulin API Sales by Application (2015-2020) (Kg)
Table 84. Latin America Insulin API Sales Market Share by Application (2015-2020)
Table 85. Latin America Insulin API Sales by Countries (2015-2020) (Kg)
Table 86. Latin America Insulin API Sales Market Share by Countries (2015-2020)
Table 87. Latin America Insulin API Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Insulin API Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Insulin API Sales by Type (2015-2020) (Kg)
Table 90. Middle East and Africa Insulin API Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Insulin API Sales by Application (2015-2020) (Kg)
Table 92. Middle East and Africa Insulin API Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Insulin API Sales by Countries (2015-2020) (Kg)
Table 94. Middle East and Africa Insulin API Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Insulin API Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Insulin API Revenue Market Share by Countries (2015-2020)
Table 97. Novo Nordisk Company Details
Table 98. Novo Nordisk Description and Business Overview
Table 99. Novo Nordisk Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 100. Novo Nordisk Insulin API Sales Growth Rate (2015-2020)
Table 101. Novo Nordisk Insulin API Sales Market Share in Global Market
Table 102. Novo Nordisk Recent Development
Table 103. Sanofi-Aventis Company Details
Table 104. Sanofi-Aventis Description and Business Overview
Table 105. Sanofi-Aventis Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 106. Sanofi-Aventis Insulin API Sales Growth Rate (2015-2020)
Table 107. Sanofi-Aventis Insulin API Sales Market Share in Global Market
Table 108. Sanofi-Aventis Recent Development
Table 109. Eli Lilly Company Details
Table 110. Eli Lilly Description and Business Overview
Table 111. Eli Lilly Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 112. Eli Lilly Insulin API Sales Growth Rate (2015-2020)
Table 113. Eli Lilly Insulin API Sales Market Share in Global Market
Table 114. Eli Lilly Recent Development
Table 115. Tonghua Dongbao Company Details
Table 116. Tonghua Dongbao Description and Business Overview
Table 117. Tonghua Dongbao Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 118. Tonghua Dongbao Insulin API Sales Growth Rate (2015-2020)
Table 119. Tonghua Dongbao Insulin API Sales Market Share in Global Market
Table 120. Tonghua Dongbao Recent Development
Table 121. United Laboratory Company Details
Table 122. United Laboratory Description and Business Overview
Table 123. United Laboratory Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 124. United Laboratory Insulin API Sales Growth Rate (2015-2020)
Table 125. United Laboratory Insulin API Sales Market Share in Global Market
Table 126. United Laboratory Recent Development
Table 127. Biocon Company Details
Table 128. Biocon Description and Business Overview
Table 129. Biocon Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 130. Biocon Insulin API Sales Growth Rate (2015-2020)
Table 131. Biocon Insulin API Sales Market Share in Global Market
Table 132. Biocon Recent Development
Table 133. Torrent Pharma Company Details
Table 134. Torrent Pharma Description and Business Overview
Table 135. Torrent Pharma Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 136. Torrent Pharma Insulin API Sales Growth Rate (2015-2020)
Table 137. Torrent Pharma Insulin API Sales Market Share in Global Market
Table 138. Torrent Pharma Recent Development
Table 139. Amphastar Company Details
Table 140. Amphastar Description and Business Overview
Table 141. Amphastar Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 142. Amphastar Insulin API Sales Growth Rate (2015-2020)
Table 143. Amphastar Insulin API Sales Market Share in Global Market
Table 144. Amphastar Recent Development
Table 145. Ganlee Company Details
Table 146. Ganlee Description and Business Overview
Table 147. Ganlee Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 148. Ganlee Insulin API Sales Growth Rate (2015-2020)
Table 149. Ganlee Insulin API Sales Market Share in Global Market
Table 150. Ganlee Recent Development
Table 151. Julphar Diabetes Company Details
Table 152. Julphar Diabetes Description and Business Overview
Table 153. Julphar Diabetes Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 154. Julphar Diabetes Insulin API Sales Growth Rate (2015-2020)
Table 155. Julphar Diabetes Insulin API Sales Market Share in Global Market
Table 156. Julphar Diabetes Recent Development
Table 157. Wockhardt Company Details
Table 158. Wockhardt Description and Business Overview
Table 159. Wockhardt Insulin API Sales (Kg), Revenue (Million US$), Price (K USD/Kg) and Gross Margin (2015-2020)
Table 160. Wockhardt Insulin API Sales Growth Rate (2015-2020)
Table 161. Wockhardt Insulin API Sales Market Share in Global Market
Table 162. Wockhardt Recent Development
Table 163. Insulin API Distributors List
Table 164. Insulin API Customers List
Table 165. Global Insulin API Sales Forecast 2021-2026 (Kg) & (Million US$)
Table 166. Global Insulin API Sales Forecast by Type 2021-2026 (Kg)
Table 167. Global Insulin API Sales Forecast by Application 2021-2026 (Kg)
Table 168. Global Insulin API Sales Forecast by Regions 2021-2026 (Kg)
Table 169. Global Insulin API Revenue Forecast by Regions 2021-2026 (Million US$)
Table 170. North America Insulin API Sales Forecast by Countries 2021-2026 (Kg)
Table 171. North America Insulin API Revenue Forecast by Countries 2021-2026
Table 172. Europe Insulin API Sales Forecast by Countries 2021-2026 (Kg)
Table 173. Europe Insulin API Revenue Market Share Forecast by Countries 2021-2026
Table 174. Asia Pacific Insulin API Sales Forecast by Regions 2021-2026 (Kg)
Table 175. Asia Pacific Insulin API Revenue Forecast by Regions 2021-2026 (Million US$)
Table 176. Latin America Insulin API Sales Forecast by Countries 2021-2026 (Kg)
Table 177. Latin America Insulin API Revenue Forecast by Countries 2021-2026 (Million US$)
Table 178. Middle East and Africa Insulin API Sales Forecast by Regions 2021-2026 (Kg)
Table 179. Middle East and Africa Insulin API Revenue Forecast by Regions 2021-2026 (Million US$)
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Insulin API Product Picture
Figure 2. Global Insulin API Sales Market Shar by Type 2015-2026
Figure 3. Regular Human Insulin Figures
Figure 4. Insulin Analogue Figures
Figure 5. Global Insulin API Sales Market Share by Application in 2019 & 2026
Figure 6. Fast-acting Use Case
Figure 7. Premix Use Case
Figure 8. Long-acting Use Case
Figure 9. Insulin API Report Years Considered
Figure 10. Global Insulin API Market Size 2015-2026 (Million US$)
Figure 11. Global Insulin API Sales 2015-2020 (Kg)
Figure 12. Global Insulin API Market Size Market Share by Regions 2015-2020
Figure 13. Global Insulin API Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Insulin API Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Insulin API Sales in 2019
Figure 17. Insulin API Value Share by Manufacturers in 2019
Figure 18. Insulin API Revenue Share by Manufacturers In 2019
Figure 19. Insulin API Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Insulin API Revenue Share by Type (2015-2020)
Figure 21. Global Insulin API Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Insulin API Market Share by Price Range (2015-2020)
Figure 23. Global Insulin API Revenue Share by Application (2015-2020)
Figure 24. Global Insulin API Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Insulin API Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 27. Canada Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 28. Europe Insulin API Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 30. France Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 31. U.K. Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 32. Italy Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 33. Russia Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 34. Asia Pacific Insulin API Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 36. Japan Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 37. South Korea Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 38. India Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 39. Australia Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 40. Taiwan Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 41. Indonesia Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 42. Thailand Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 43. Malaysia Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 44. Philippines Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 45. Vietnam Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 46. Latin America Insulin API Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 48. Brazil Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 49. Argentina Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 50. Middle East and Africa Insulin API Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 52. Saudi Arabia Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 53. U.A.E Insulin API Sales Growth Rate (2015-2020) (Kg)
Figure 54. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sanofi-Aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Tonghua Dongbao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. United Laboratory Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Biocon Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Torrent Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Amphastar Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Ganlee Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Julphar Diabetes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Insulin API Value Chain
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
Figure 68. North America Insulin API Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 69. North America Insulin API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 70. Europe Insulin API Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 71. Europe Insulin API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 72. Asia Pacific Insulin API Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 73. Asia Pacific Insulin API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 74. Latin America Insulin API Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 75. Latin America Insulin API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 76. Middle East and Africa Insulin API Sales Growth Rate Forecast (2021-2026) (Kg)
Figure 77. Middle East and Africa Insulin API Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed



• 英文レポート名:Global Insulin API Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
• 日本語訳:世界のインスリンAPI産業2020-2026
• レポートコード:D0MA3012024お問い合わせ(見積依頼・ご注文・質問)